Ryan Cross
Company: Endpoints News
Job title: Senior Science Correspondent
Seminars:
Fireside Chat: TPD – Where Are We Now & Where Are We Going? 8:30 am
A sit down conversation with Kymera Therapeutics’ Chief Executive Officer, Nello Mainolfi on his thoughts on strategy, current roadblocks, and future directions for the targeted protein degradation fieldRead more
day: Day One AM